Only $2.99/month

Terms in this set (361)

People aged 65 or older (both PCV 13 and PPSV 23 vaccines - see below details for timing)
People with CSF leak (both PCV 13 and PPSV 23 vaccines - see below details for timing)
Immunocompromised patients* (both PCV 13 and PPSV 23 vaccines - see below details for timing)
People with chronic illness** (only PPSV23 - see below details for timing)
Smokers and people living in special environments (only PPSV23 - see below details for timing)
PCV13: Only a single dose of PCV13 is recommended over the entire lifetime of an adult.

PPSV23: This vaccine is given at least twice to patients as long as the first dose was given to the patient before turning 65 years old. The second dose is given no sooner than 5 years after the first dose. Previously unimmunized 65 year old or older patients should only receive one dose of PPSV23 in their remaining life time; the dose should be given as soon as possible.

Partly immunized patients - missing PCV13: In patients who have only received PPSV23 and have indications for both vaccines, PCV 13 should be given no sooner than 1 year after the last PPSV23.

Partly immunized patients - missing PPSV23: In patients, who have received PCV13 and who have indications for both vaccines, PPSV 23 should be given no sooner than 6-12 months after the PCV13 vaccination.

Unimmunized patients requiring both PCV13 and PPSV23: In patients with indications for both vaccines, PCV 13 should be given first and PPSV23 should be given no sooner than 6 to 12 months after the PCV13 vaccination.

* Immunocompromised patients: those with splenic dysfunction or asplenia, hematologic malignancy, multiple myeloma, renal failure, organ transplants, HIV infection.

** People with chronic illness: cardiovascular (eg, congestive heart failure and cardiomyopathies) and pulmonary diseases (including COPD and emphysema but not asthma), diabetes mellitus, alcoholism, and chronic liver failure.